Browsing Tag
PrecivityAD2
3 posts
C2N Diagnostics wins FDA clearance for PrecivityAD2 as Alzheimer’s blood testing race widens
C2N Diagnostics has secured FDA clearance for PrecivityAD2, extending regulated Alzheimer’s blood testing to symptomatic adults as young as 40 and intensifying competition with established diagnostic platforms.
C2N Diagnostics bags UK MHRA approval for PrecivityAD2 blood test, advancing Alzheimer’s diagnosis
C2N Diagnostics, LLC, a leader in advanced diagnostic solutions for neurodegenerative diseases, has obtained medical device certification from…
C2N’s PrecivityAD2 blood test improves Alzheimer’s diagnosis and clinical decision-making, study finds
A new study has demonstrated that healthcare providers who used the PrecivityAD2 blood biomarker test, developed by C2N…